2020
DOI: 10.1016/j.psym.2020.05.023
|View full text |Cite
|
Sign up to set email alerts
|

Mania Associated With Supratherapeutic Tacrolimus Levels in a Patient With No Psychiatric History

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…10–12 Supratherapeutic tacrolimus level is associated with mania. 13 As tacrolimus level can be varied with telaprevir, a substrate of both CYP3A4 and P-glycoprotein, 14 low-dose aripiprazole may also have similar effect and cause hypomanic/manic symptom. The patient who received ECT also received venlafaxine, 4 a substrate of P-glycoprotein and was reported to have increased 5-HT effect, causing toxic symptoms when administered with tacrolimus.…”
Section: Discussionmentioning
confidence: 99%
“…10–12 Supratherapeutic tacrolimus level is associated with mania. 13 As tacrolimus level can be varied with telaprevir, a substrate of both CYP3A4 and P-glycoprotein, 14 low-dose aripiprazole may also have similar effect and cause hypomanic/manic symptom. The patient who received ECT also received venlafaxine, 4 a substrate of P-glycoprotein and was reported to have increased 5-HT effect, causing toxic symptoms when administered with tacrolimus.…”
Section: Discussionmentioning
confidence: 99%